X0609 4 2026-10-01 0 0001666071 Cardlytics, Inc. CDLX 0001961238 Gupta Amit false 675 PONCE DE LEON AVENUE NE SUITE 4100 ATLANTA GA 30308 1 1 0 0 Chief Executive Officer 0 Common Stock 2026-10-01 4 M 0 18750 A 144139 D Common Stock 2026-10-01 4 M 0 12500 A 156639 D Common Stock 2026-10-01 4 S 0 10351 2.71 D 146288 D Common Stock 2026-10-02 4 S 0 7382 2.533 D 138906 D Restricted Stock Units 2026-10-01 4 M 0 18750 0 D Common Stock 18750 112500 D Restricted Stock Unit 2026-10-01 4 M 0 12500 0 D Common Stock 12500 25000 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.62 to $2.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $2.48 to $2.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3). The RSUs vest in equal amounts quarterly over a two-year period through April 1, 2028, provided that the Reporting Person remains employed by the Issuer on such vesting dates. 50% of the shares underlying the RSU award vested on April 1, 2026, with the remaining 50% vesting in equal amounts quarterly over a one-year period through April 1, 2027, provided that the Reporting Person remains employed by the Issuer on such vesting dates. /s/ Chris Cheng, Attorney-in-Fact 2026-10-02